AKT inhibitors: A new type of targeted cancer drug
Institute of Cancer Research News | May 13, 2022
Fluorescent probe can track cancer drug progress, study shows
MedicalXpress Breaking News-and-Events | May 12, 2022
Methylation of tRNA-derived fragments regulates gene-silencing activity in bladder cancer
MedicalXpress Breaking News-and-Events | May 11, 2022
Strategy overcomes EZH2 inhibitor resistance in SMARCB1-mutated cancer
MedicalXpress Breaking News-and-Events | May 11, 2022
Exposure to wildfires increases risk of cancer
MedicalXpress Breaking News-and-Events | May 11, 2022
T cell behavior determines which tumors respond to treatment
MedicalXpress Breaking News-and-Events | May 10, 2022
Common genetic mutation allows cancer cells to gain extra chromosomes that help them survive
MedicalXpress Breaking News-and-Events | May 10, 2022
Targeting interleukin-6 could help relieve immunotherapy side effects
MedicalXpress Breaking News-and-Events | May 10, 2022
NIR-II-responsive nickel-based therapy provides new solution for synergistic oncotherapy
MedicalXpress Breaking News-and-Events | May 10, 2022
Dairy products linked to increased risk of cancer
MedicalXpress Breaking News-and-Events | May 07, 2022